Navigation Links
Mullins Introducer Sheaths/Brockenbrough Needles

ProductsMullins Introducer Sheaths/Brockenbrough Needles
Company Medtronic Inc.
Item Mullins Introducer Sheaths/Brockenbrough Needles
Features 
  • The Medtronic Brockenbrough curved needle is made up of an outer cannula and an inner stylet.
  • The outer cannula is made of flexible thin-walled tubing.
  • The inner stylet is solid, much stiffer and closely fitting, whose sharpened end protrudes 2-3 mm beyond the tip of the cannula.
  • The Brockenbrough curved needle is used in conjunction with transseptal catheters to puncture the atrial septum to allow conducting a left heart catheterization procedure through the right atrium.
  • The Brockenbrough curved needle is intended for single use only.
  • Description EP Systems sells the popular transeptal Mullins introducer sheaths, and Brockenbrough curved needles. These products allow left atrial access from the venous system for catheter ablation of left-sided arrhythmogenic substrates. Many physicians prefer the transseptal approach; others use it when a transaortic (retrograde) approach is contraindicated. The stainless steel Brockenbrough needle is used to make the transseptal puncture, while the Mullins introducer sheath/dilator set serve as a conduit for the needle and the electrophysiology catheters. The needles are supplied sterile, and must be sterilized before use.
    Info Medtronic Inc.
    Customer Service: (800) 551-5544
    Web site: http://www.medtronic.com/

    Related medicine products :

    1. Carter Sphere Introducer and Holder
    2. Sphere Introducer
    3. Fast-Cath & Maximum Hemostasis Introducers
    4. Ultimum Introducers
    5. Fast-Cath Hemostasis Introducers
    6. Maximum Hemostasis Introducers
    7. Fast-Cath Guiding Introducers
    8. Convoy Catheter Introducer Sheaths
    9. Fast-Cath Duo Guiding Introducers
    10. Fast-Cath Duo Hemostasis Introducers
    11. Fast-Cath Trio Hemostasis Introducers
    ... an innovative handheld device for ... non-invasively, comfortably, and accurately.,It is, ... than an automatic blood pressure ... charge, Vasotrax will take approximately ...
    ... Insulin-like growth factor II (IGF-II) is a 7.5 ... liver and is postulated to have mitogenic and ... of IGF-II are mediated by binding to target ... the Type II IGF receptor, a monomeric protein ...
    ... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
    ... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
    Medicine Products:
    (Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
    (Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
    (Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
    (Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
    (Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
    Breaking Medicine News(10 mins):
    (Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
    (Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
    (Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
    Breaking Medicine Technology: